HYPERPHOSPHATEMIA PATIENTS ON PERITONEAL DIALYSIS

Clinical trials for HYPERPHOSPHATEMIA PATIENTS ON PERITONEAL DIALYSIS explained in plain language.

Never miss a new study

Get alerted when new HYPERPHOSPHATEMIA PATIENTS ON PERITONEAL DIALYSIS trials appear

Sign up with your email to follow new studies for HYPERPHOSPHATEMIA PATIENTS ON PERITONEAL DIALYSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for dialysis patients: TS-172 aims to tame dangerous phosphorus levels

Disease control Not yet recruiting

This study tests an experimental drug called TS-172 in 30 adults on peritoneal dialysis who have high phosphorus levels (hyperphosphatemia). The goal is to see if the drug helps more patients reach a safe phosphorus level in their blood. Participants will take TS-172 alongside th…

Matched conditions: HYPERPHOSPHATEMIA PATIENTS ON PERITONEAL DIALYSIS

Phase: PHASE3 • Sponsor: Taisho Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated May 06, 2026 16:03 UTC

HYPERPHOSPHATEMIA PATIENTS ON PERITONEAL DIALYSIS

Get alerted when new HYPERPHOSPHATEMIA PATIENTS ON PERITONEAL DIALYSIS trials appear

New hope for dialysis patients: TS-172 aims to tame dangerous phosphorus levels